EME Equity Market – April 2024 Market performance – green across all geographies, with Turkey outperforming. The MSCI EM Europe Index was up 5.3% mom in EUR terms and 4.2% mom in USD in April; while the Turkish ISE30 saw the strongest performance, adding 11.6% mom; followed by the Hungarian BUX (+5.0% mom); the Czech PX (+2.8% mom); the Greek ASE (+1.8% mom), the Polish WIG20 (+1.2% mom) and the Romanian BET (+0.1% mom) (all in EUR terms).
March underperformance sparked repositioning opportunity; risk-reward compelling – Greek bank shares had a strong start to 2024 (until Feb) closing the valuation gap vs EU periphery peers buoyed by the stellar 2023 profits (adj. RoTE of c16%), successful B/S de-risking (NPE ratio c4%) and improved market liquidity post HFSF’s placements. However, in March they suffered a bout of underperformance (>15%), with the relative 2024e P/TBV discount widening to c20% (and the P/E discount even higher) on...
March underperformance sparked repositioning opportunity; risk-reward compelling – Greek bank shares had a strong start to 2024 (until Feb) closing the valuation gap vs EU periphery peers buoyed by the stellar 2023 profits (adj. RoTE of c16%), successful B/S de-risking (NPE ratio c4%) and improved market liquidity post HFSF’s placements. However, in March they suffered a bout of underperformance (>15%), with the relative 2024e P/TBV discount widening to c20% (and the P/E discount even higher) on...
A director at Alpha Services and Holdings S.A sold 48,170 shares at 1.573EUR and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...
3QFY24: Expected Sequential Recovery As Earnings Meet Expectations Performance improved sequentially due to fewer doctors being on long leave. It is even more impressive given that the quarter is a seasonal low. Ultimately, earnings are within our expectations. The quarters ahead should grow from strength to strength, starting with Alhaya. We like Alpha IVF for its industry-leading success rates, growth off a low base, and superior margins relative to its peers. Maintain BUY. Target price: RM0.4...
GREATER CHINA Economics Economic Activity: 1Q24 surprises with 5.3% yoy growth. Sector Hong Kong Property: Expect modest pull-back of primary sales in 2Q24; we prefer retail landlords over developers. Top pick: Wharf REIC. INDONESIA Sector Consumer: Cocoa price spikes accompanied by increases in sugar and coffee prices. MALAYSIA Initiate Coverage Sime Darby (SIME MK/BUY/RM2.76/Target: RM3.13): A conglomerate giant speeding to the top. Results Alpha IVF (ALPHA MK/BUY/RM0.34/Target: RM0.40): 3QF...
HEADLINES: • Greek banks: life after the windfall (Alpha, Eurobank, NBG and Piraeus – transfer of coverage) • Cyfrowy Polsat: key takeaways from the 4Q23 earnings call NEUTRAL • Orlen: announces PLN 1.6bn of probable trading losses NEGATIVE • ING BSK: AGM approves PLN 33.35 DPS NEUTRAL • Public Power Corporation: partners with Mytilineos for 2GW solar portfolio NEUTRAL • InPost: PPF realises option to buy 10% stake • ONE United Properties: founders and others selling up to 9.5% in ABB • PKO BP: ...
We are revisiting and transferring coverage of the Greek banks. We estimate their earnings to plateau, and their ROTEs to normalise in 2024-26E, as the market expects short-term Euribor rates to decline. Capital and liquidity gain importance as there is less easy money. The emphasis will be on optimising balance sheets, returning capital, and minimising funding costs relative to Euribor. We like National Bank of Greece (NBG; BUY) for its profitability, simplicity, and potential to return capital...
Fertilising Alpha Growth A distinguished fertility group, Alpha IVF is poised to extend its established footprint into neighbouring countries. Strategic expansion into underserved markets and segments, alongside favourable industry trends, fuels our projected three-year earnings growth at an impressive three-year CAGR of 19.0% (FY23-36). Its margins surpass those of its peers, showcasing Alpha IVF’s leading capabilities and execution. Initiate coverage with BUY and target price of RM0.40.
GREATER CHINA Update Sino Biopharmaceutical (1177 HK/BUY/HK$2.83/Target: HK$3.80): Enters into strategic partnership with Boehringer Ingelheim. MALAYSIA Initiate Coverage Alpha IVF (ALPHA MK/BUY/RM0.33/Target: RM0.40): Initiate coverage on Alpha IVF with a BUY call. Alpha IVF offers industry-leading success rates, which are expected to be replicated across its exciting regional expansion. SINGAPORE Sector Banking: Higher for slightly longer. THAILAND Update CP ALL (CPALL TB/BUY/Bt56.00/Target...
Fertilising Alpha Growth A distinguished fertility group, Alpha IVF is poised to extend its established footprint into neighbouring countries. Strategic expansion into underserved markets and segments, alongside favourable industry trends, fuels our projected three-year earnings growth at an impressive three-year CAGR of 19.0% (FY23-36F). Its margins surpass those of its peers, showcasing Alpha IVF’s leading capabilities and execution. Initiate coverage with BUY and target price of RM0.40.
EME Equity Market – March 2024 Market performance – mixed performances in March, with the Romanian BET outperforming. The MSCI EM Europe Index declined by 0.3% mom in EUR terms and 0.4% mom in USD in March. The Romanian BET reported the strongest performance, adding 7.1% mom in EUR terms, followed by the Czech PX and the Polish WIG20 (+4.1% and 1.0% mom, in EUR terms, respectively). Greece saw a relatively muted performance (-0.2% mom in EUR terms), while Hungary (-1.1% mom in EUR terms) and Tür...
Alpha Bank (Alpha) reported €611m in net profit, a 66% jump from FY22, as the bank benefited from an elevated interest rate environment with little impact from deposit migration and strong cost control. Alpha delivered a normalised return on tangible equity (RoTE) of 12.9% in FY23, beating its own upgraded target of >11.5%. The increased profitability coupled with a robust capital position (fully loaded common equity tier 1 (FL CET1) of 14.3%) have enabled a proposed dividend of €0.05 a share, s...
Two Directors at Piraeus Financial Holdings S.A. sold 11,000 shares at between 3.958EUR and 3.968EUR. The significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's direc...
HEADLINES: • OTP Bank: 4Q23 profits largely in line; 2024E guidance assumes continuation of profits, but ROE is likely start to normalise • Alpha Bank: 4Q23 highlights • Eurobank: 4Q23 highlights • Fondul Proprietatea: Court of Appeal admits Fund’s request to annul share capital increase decision at Bucharest Airports POSITIVE • Arcelik: CMA approves Arcelik-Whirlpool Deal POSITIVE • DataWalk: key takeaways from the preliminary 4Q23 earnings call POSITIVE • KazMunayGas: 4Q23E results preview ...
Summary Marketline's Piraeus Bank S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Piraeus Bank S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments...
2023: Reclaiming investor spotlight – Greek equities had another year of stellar performance, with the ASE index popping >40%, eclipsing the Stoxx 600 by >25ppts. Strong fundamentals (mid-teens EBITDA growth for non-financials, >50% NII growth for banks) were coupled with falling risk premia thanks to crystallized domestic political stability and expectations for Greece’s return to investment grade (IG), further propelled by the generic risk-on rally in Q4 and low positioning. Financials (+66%) ...
2023: Reclaiming investor spotlight – Greek equities had another year of stellar performance, with the ASE index popping >40%, eclipsing the Stoxx 600 by >25ppts. Strong fundamentals (mid-teens EBITDA growth for non-financials, >50% NII growth for banks) were coupled with falling risk premia thanks to crystallized domestic political stability and expectations for Greece’s return to investment grade (IG), further propelled by the generic risk-on rally in Q4 and low positioning. Financials (+66%) ...
Resilient NII despite funding challenges and likely interest rate cuts – Following a >50% surge in NII in 2023e (58% in the 9m period), investor focus has been clearly shifting to prospects for 2024-25e, especially in view of likely rate cuts. Despite the upcoming peak in NII (in Q4’23 or Q1’24), we project resilience in 2024, supported by credit growth (c4% p.a. in 2024-25e), the gradual benefit from deposit hedges (contributing c4% of NII by 2025e) as well as the lower-than-anticipated deposit...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.